Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules Farhat Nasim28 May 2019 10:00 AM ISTThe approved product, Methylphenidate Hydrochloride extended-release capsules, is bioequivalent to the reference listed drug product (RLD), Ritalin LA...
Novartis wins USFDA approval for first PI3K inhibitor for breast cancer Farhat Nasim27 May 2019 6:10 PM ISTThe drug, alpelisib, to be marketed under the brand name Piqray, belongs to a class of drugs known as PI3K inhibitors and is the first of its kind to...
Novartis gets USFDA nod for over Rs 13 crore gene therapy Zolgensma Farhat Nasim25 May 2019 10:00 AM ISTThe Food and Drug Administration on Friday approved the treatment, called Zolgensma, for all children under age 2 who are confirmed by a genetic test...
Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution Farhat Nasim2 May 2019 4:04 PM ISTOlopatadine Hydrochloride Ophthalmic Solution USP, 0.2% is indicated for the treatment of ocular itching associated with allergic conjunctivitis.New...
Alembic Pharma gets USFDA nod toTeriflunomide tablets, Tobramycin ophthalmic solution Farhat Nasim22 April 2019 11:55 AM ISTTeriflunomide tablets are indicated for the treatment of patients with relapsing forms of multiple sclerosis while Tobramycin ophthalmic solution is a...
Alcon sees India as key growth engine for business; to focus on surgical, vision care, dry eye portfolios Medical Dialogues Bureau11 April 2019 9:05 AM ISTWith the completion of the spin-off, Alcon will become the largest eye care devices company in the world, he added.New Delhi: Global eye care major...
Novartis division Alcon spinoff ousts Baer from Swiss benchmark SMI Medical Dialogues Bureau5 April 2019 9:00 AM ISTNovartis has estimated Alcon's value at around 25 billion Swiss francs ($25 billion), while some analysts predict an initial market capitalisation of...
Novartis division resubmits USFDA application for biosimilar Pegfilgrastim Farhat Nasim4 April 2019 9:15 AM ISTNew Delhi: Novartis division, Sandoz, recently announced resubmission of its Biologics License Application (BLA) for a proposed biosimilar...
Novartis to face lawsuit over doctor kickbacks Garima3 April 2019 9:10 AM ISTThe case began in 2011 as a whistleblower lawsuit filed by Oswald Bilotta, a former Novartis sales representative. Such lawsuits, brought under the...
Novartis to pay $310 million for assets from inflammation specialist IFM Garima2 April 2019 9:00 AM ISTIFM, whose research head Martin Seidel spent more than a decade at Novartis before assuming R&D duties at IFM in 2017, focuses on immune system...
Novartis division Alcon acquires Power Vision Garima20 March 2019 9:47 AM ISTUnder the terms of the agreement, Alcon, a Novartis division paid USD 285 million to PowerVision at closing with additional payments based on...
Lupin, Natco receives USFDA nod for Imatinib Mesylate tablets Farhat Nasim6 March 2019 9:30 AM ISTImatinib Mesylate is a generic version of Novartis Pharmaceuticals Corporation's Gleevec tablets in the same strengths, Lupin said in a filing to BSE....
